05
Nov
Nov
A poorly characterized protein, historically considered a chaperone or enzyme, may actually play a key role in prostate cancer. In a systematic CRISPR screen, researchers from the Arc Institute at the University of California and the Fred Hutchinson Cancer Center identified PTGES3, known as the third protein of prostaglandin E synthase, as an unexpected regulator […]